Quick Answer
PharmaCyte Biotech, Inc. reported Total Revenue of $0.00 for fiscal year 2025.
PharmaCyte Biotech, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $0.00 | — |
| 2024 | $0.00 | — |
| 2023 | $0.00 | — |
| 2022 | $0.00 | — |
| 2021 | $0.00 | — |
| 2020 | $0.00 | — |
| 2019 | $0.00 | — |
| 2018 | $0.00 | — |
| 2017 | $0.00 | — |
| 2016 | $0.00 | — |
| 2015 | $0.00 | — |
| 2014 | $0.00 | -100.0% |
| 2013 | $12.2K | -81.7% |
| 2012 | $66.6K | -47.2% |
| 2011 | $126.0K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $0.00 | — | — |
| October 31, 2025 | $0.00 | — | — |
| July 31, 2025 | $0.00 | — | — |
| January 31, 2025 | $0.00 | — | — |
| October 31, 2024 | $0.00 | — | — |
| July 31, 2024 | $0.00 | — | — |
| January 31, 2024 | $0.00 | — | — |
| October 31, 2023 | $0.00 | — | — |
- Over the 2011–2025 period, PharmaCyte Biotech, Inc.’s total revenue has declined by 100.0% (from $126.0 thousand to $0.00).
- The most recent figure is from PharmaCyte Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 11, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: